Total Payments
$2,210
2024 Payments
$156.66
Companies
19
Transactions
178
Medicare Patients
660
Medicare Billing
$169,098
Payment Breakdown by Category
Food & Beverage$2,207 (99.8%)
Education$3.57 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,207 | 172 | 99.8% |
| Education | $3.57 | 6 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $969.28 | 69 | $0 (2024) |
| Daiichi Sankyo Inc. | $345.47 | 51 | $0 (2018) |
| Collegium Pharmaceutical, Inc. | $185.61 | 13 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $160.04 | 11 | $0 (2017) |
| Amgen Inc. | $114.06 | 7 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $63.04 | 4 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $58.74 | 3 | $0 (2021) |
| BioDelivery Sciences International, Inc. | $54.40 | 3 | $0 (2019) |
| RedHill Biopharma Inc. | $48.62 | 3 | $0 (2021) |
| Valinor Pharma, LLC | $48.05 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $156.66 | 10 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($112.14) |
| 2023 | $119.27 | 8 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($87.17) |
| 2022 | $241.83 | 18 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($165.26) |
| 2021 | $288.46 | 19 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($115.21) |
| 2020 | $227.16 | 15 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($106.13) |
| 2019 | $329.25 | 22 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($212.43) |
| 2018 | $371.29 | 37 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($170.94) |
| 2017 | $476.49 | 49 | Daiichi Sankyo Inc. ($188.75) |
All Payment Transactions
178 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Gastroenterology | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Gastroenterology | ||||||
| 07/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Gastroenterology | ||||||
| 05/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Gastroenterology | ||||||
| 04/05/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Gastroenterology | ||||||
| 01/26/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.22 | General |
| Category: Opioid Analgesic | ||||||
| 01/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Gastroenterology | ||||||
| 01/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Gastroenterology | ||||||
| 11/01/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Gastroenterology | ||||||
| 09/22/2023 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Pain Management | ||||||
| 08/22/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Gastroenterology | ||||||
| 06/28/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Gastroenterology | ||||||
| 04/19/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Gastroenterology | ||||||
| 03/15/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Gastroenterology | ||||||
| 03/10/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $14.35 | General |
| Category: Opioid Analgesic | ||||||
| 02/15/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Gastroenterology | ||||||
| 12/21/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Gastroenterology | ||||||
| 11/30/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $9.21 | General |
| Category: Gastroenterology | ||||||
| 11/09/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Gastroenterology | ||||||
| 10/12/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Gastroenterology | ||||||
| 08/31/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Gastroenterology | ||||||
| 08/24/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $7.35 | General |
| Category: Gastroenterology | ||||||
| 08/01/2022 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $15.11 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 136 | 1,084 | $108,287 | $34,051 |
| 2022 | 4 | 137 | 1,632 | $139,363 | $46,714 |
| 2021 | 7 | 180 | 1,623 | $143,648 | $46,986 |
| 2020 | 6 | 207 | 1,604 | $137,872 | $41,347 |
Total Patients
660
Total Services
5,943
Medicare Billing
$169,098
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 178 | $48,060 | $15,399 | 32.0% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 27 | 156 | $23,868 | $6,423 | 26.9% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 26 | 135 | $19,035 | $5,194 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 69 | $12,696 | $4,748 | 37.4% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 30 | 546 | $4,628 | $2,287 | 49.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 271 | $73,170 | $25,585 | 35.0% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 35 | 223 | $34,119 | $9,618 | 28.2% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2022 | 30 | 194 | $27,354 | $7,847 | 28.7% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 36 | 944 | $4,720 | $3,664 | 77.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 39 | 231 | $62,370 | $20,885 | 33.5% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2021 | 31 | 216 | $33,048 | $9,326 | 28.2% |
| 20552 | Injections of trigger points in 1 or 2 muscles | Office | 2021 | 28 | 177 | $24,957 | $7,454 | 29.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2021 | 34 | 932 | $4,660 | $3,613 | 77.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 37 | $6,808 | $2,490 | 36.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 15 | 15 | $7,815 | $2,123 | 27.2% |
| 76705 | Ultrasound of abdomen, limited | Office | 2021 | 11 | 15 | $3,990 | $1,095 | 27.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 41 | 173 | $46,710 | $13,646 | 29.2% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2020 | 40 | 212 | $32,436 | $8,883 | 27.4% |
| 20552 | Injections of trigger points in 1 or 2 muscles | Office | 2020 | 35 | 166 | $23,406 | $7,009 | 29.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 37 | 130 | $23,920 | $6,746 | 28.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2020 | 41 | 900 | $4,500 | $3,469 | 77.1% |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2020 | 13 | 23 | $6,900 | $1,594 | 23.1% |
About Dr. Sam Martin, MD
Dr. Sam Martin, MD is a Interventional Pain Medicine healthcare provider based in Brentwood, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154376788.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sam Martin, MD has received a total of $2,210 in payments from pharmaceutical and medical device companies, with $156.66 received in 2024. These payments were reported across 178 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,207).
As a Medicare-enrolled provider, Martin has provided services to 660 Medicare beneficiaries, totaling 5,943 services with total Medicare billing of $169,098. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Location Brentwood, MO
- Active Since 05/23/2006
- Last Updated 08/18/2014
- Taxonomy Code 208VP0014X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1154376788
Products in Payments
- RELISTOR (Drug) $798.34
- RELISTOR ORAL (Drug) $330.98
- Morphabond ER (Drug) $239.10
- XTAMPZA (Drug) $171.26
- Movantik (Drug) $154.70
- Aimovig (Biological) $114.06
- MOVANTIK (Drug) $111.09
- AIMOVIG (Biological) $58.74
- BUNAVAIL 2.1 mg 30-count box (Drug) $54.40
- Nucynta (Drug) $39.24
- NURTEC ODT (Drug) $27.20
- OXYCONTIN (Drug) $23.97
- Puraply (Medical Supply) $18.81
- EMGALITY (Drug) $18.13
- Belbuca (Drug) $14.35
- Levorphanol Tartrate (Drug) $13.38
- Hymovis (Device) $11.44
- Symproic (Drug) $10.93
- MORPHABOND ER (Drug) $0.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.